Unknown

Dataset Information

Epigenetic profiling for prognostic stratification and personalized therapy in breast cancer.


ABSTRACT:

Background

The rising incidence of breast cancer and its heterogeneity necessitate precise tools for predicting patient prognosis and tailoring personalized treatments. Epigenetic changes play a critical role in breast cancer progression and therapy responses, providing a foundation for prognostic model development.

Methods

We developed the Machine Learning-derived Epigenetic Model (MLEM) to identify prognostic epigenetic gene patterns in breast cancer. Using multi-cohort transcriptomic datasets, MLEM was constructed with rigorous machine learning techniques and validated across independent datasets. The model's performance was further corroborated through immunohistochemical validation on clinical samples.

Results

MLEM effectively stratified breast cancer patients in

SUBMITTER: Guo X 

PROVIDER: S-EPMC11772270 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature